These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6783626)

  • 21. Physicochemical properties of pyocin F1.
    Kuroda K; Kageyama M; Maeda T; Fujime S
    J Biochem; 1979 Jan; 85(1):21-8. PubMed ID: 104987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of bacteriocin production by clinical Pseudomonas aeruginosa isolates and their potential as therapeutic agents.
    Charkhian H; Soleimannezhadbari E; Bodaqlouei A; Lotfollahi L; Lotfi H; Yousefi N; Shojadel E; Gholinejad Z
    Microb Cell Fact; 2024 Jun; 23(1):175. PubMed ID: 38872163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery, characterization and in vivo activity of pyocin SD2, a protein antibiotic from Pseudomonas aeruginosa.
    McCaughey LC; Josts I; Grinter R; White P; Byron O; Tucker NP; Matthews JM; Kleanthous C; Whitchurch CB; Walker D
    Biochem J; 2016 Aug; 473(15):2345-58. PubMed ID: 27252387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Colicin M-Type Bacteriocin from Pseudomonas aeruginosa Targeting the HxuC Heme Receptor Requires a Novel Immunity Partner.
    Ghequire MGK; Öztürk B
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyocin inhibition of Neisseria gonorrhoeae: mechanism of action.
    Morse SA; Jones BV; Lysko PG
    Antimicrob Agents Chemother; 1980 Sep; 18(3):416-23. PubMed ID: 6775595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A simple photometric method for determination of the activity of pyrocin R1.
    Kumazaki T; Ishii S
    J Biochem; 1982 Mar; 91(3):817-23. PubMed ID: 6804454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA Damage-Inducible Pyocin Expression Is Independent of RecA in
    Bronson AS; Baggett NS; Cabeen MT
    Microbiol Spectr; 2022 Aug; 10(4):e0116722. PubMed ID: 35708338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyocin-sensitivity testing as a method of typing Pseudomonas aeruginosa: use of "phage-free" preparations of pyocin.
    Rampling A; Whitby JL; Wildy P
    J Med Microbiol; 1975 Nov; 8(4):531-41. PubMed ID: 812999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structures of the Ultra-High-Affinity Protein-Protein Complexes of Pyocins S2 and AP41 and Their Cognate Immunity Proteins from Pseudomonas aeruginosa.
    Joshi A; Grinter R; Josts I; Chen S; Wojdyla JA; Lowe ED; Kaminska R; Sharp C; McCaughey L; Roszak AW; Cogdell RJ; Byron O; Walker D; Kleanthous C
    J Mol Biol; 2015 Aug; 427(17):2852-66. PubMed ID: 26215615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preferential inhibition of lipid synthesis by the bacteriocin pyocin S2.
    Okawa I; Maruo B; Kageyama M
    J Biochem; 1975 Jul; 78(1):213-23. PubMed ID: 811653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of iron concentration in the growth medium on the sensitivity of Pseudomonas aeruginosa to pyocin S2.
    Ohkawa I; Shiga S; Kageyama M
    J Biochem; 1980 Jan; 87(1):323-31. PubMed ID: 6766926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage.
    Nakayama K; Takashima K; Ishihara H; Shinomiya T; Kageyama M; Kanaya S; Ohnishi M; Murata T; Mori H; Hayashi T
    Mol Microbiol; 2000 Oct; 38(2):213-31. PubMed ID: 11069649
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pyocin types and proteolytic properties of Pseudomonas pyocyanea organisms in burned patients and in the milieu of the Division of Burns, Institute of Hematology in Warsaw].
    Bukowska D; Serafińska D; Nasilowski W; Zietkiewicz W
    Pol Tyg Lek; 1976 Jun; 31(26):1107-10. PubMed ID: 821048
    [No Abstract]   [Full Text] [Related]  

  • 34. SOS-Independent Pyocin Production in P. aeruginosa Is Induced by XerC Recombinase Deficiency.
    Baggett NS; Bronson AS; Cabeen MT
    mBio; 2021 Dec; 12(6):e0289321. PubMed ID: 34809462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dansyl chloride labeling of Pseudomonas aeruginosa treated with pyocin R1: change in permeability of the cell envelope.
    Uratani Y
    J Bacteriol; 1982 Feb; 149(2):523-8. PubMed ID: 6799489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical relationship among three F-type pyocins, pyocin F1, F2, and F3, and phage KF1.
    Kuroda K; Kagiyama R
    J Biochem; 1983 Nov; 94(5):1429-41. PubMed ID: 6654864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study on fibers isolated from four R-type pyocins, phage-tail-like bacteriocins of Pseudomonas aeruginosa.
    Kumazaki T; Ishii S
    J Biochem; 1982 Nov; 92(5):1559-66. PubMed ID: 6818225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pore-forming pyocin S5 utilizes the FptA ferripyochelin receptor to kill Pseudomonas aeruginosa.
    Elfarash A; Dingemans J; Ye L; Hassan AA; Craggs M; Reimmann C; Thomas MS; Cornelis P
    Microbiology (Reading); 2014 Feb; 160(Pt 2):261-269. PubMed ID: 24217175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between pyocin-sensitivity and 2-amino sugar composition of Pseudomonas aeruginosa.
    Suzuki N
    FEBS Lett; 1974 Nov; 48(2):301-5. PubMed ID: 4215680
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pyocin production by bacillus pyocyaneus and sensitivity of strains of different origin to them].
    Kurnosova LM; Sukhodol'skaia AE; Suvorova TI; Faustova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):8-13. PubMed ID: 6776722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.